Report on active surveillance for adverse events following the use of drug co-administrations in the global programme to eliminate lymphatic filariasis.
D016907:Adverse Drug Reaction Reporting Systems; D015766:Albendazole / Q000008:administration & dosage / Q000009:adverse effects; D000818:Animals; D004049:Diethylcarbamazine / Q000008:administration & dosage / Q000009:adverse effects; D004359:Drug Therapy, Combination; D004605:Elephantiasis, Filarial / Q000517:prevention & control*; D005369:Filaricides / Q000008:administration & dosage / Q000009:adverse effects*; D014943:Global Health; D006801:Humans; D007391:International Cooperation; D007559:Ivermectin / Q000008:administration & dosage / Q000009:adverse effects; D011159:Population Surveillance; D016730:Program Development; D014958:Wuchereria bancrofti
D005369:Filaricides; D007559:Ivermectin; D015766:Albendazole; D004049:Diethylcarbamazine